Skip to main content
. 2023 Mar 27;38(1):88–94. doi: 10.4274/MMJ.galenos.2023.29599

Figure 1.

Figure 1

Current advances and future prospects in cancer immunotherapies.

ICI: Immune checkpoint inhibitors, mAb: Monoclonal antibody